Embecta Gets FDA Clearance for Disposable Insulin Patch Pump for Diabetes

MT Newswires Live09-03

Embecta (EMBC) said Tuesday it has received the US Food and Drug Administration's 510(k) clearance for disposable patch pump for insulin delivery for the treatment of both type 1 and type 2 diabetes.

The system features a tubeless patch pump with a 300-unit insulin reservoir and a secured controller equipped with Bluetooth technology for a user-friendly interface and experience.

Embecta's said its patch pump development program also includes plans to introduce a closed-loop version featuring an insulin-dosing algorithm in a future FDA submission.

Shares of Embecta were up 2.3% in recent Tuesday trading.

Price: 16.72, Change: +0.38, Percent Change: +2.33

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2464386046?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-09-03 23:37","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2464386046","market":"nz","top_or_hot":-1,"title":"Embecta Gets FDA Clearance for Disposable Insulin Patch Pump for Diabetes","media":"MT Newswires Live","content":"<html><body><p> Embecta (EMBC) said Tuesday it has received the US Food and Drug Administration's 510(k) clearance for disposable patch pump for insulin delivery for the treatment of both type 1 and type 2 diabetes.</p><p>The system features a tubeless patch pump with a 300-unit insulin reservoir and a secured controller equipped with Bluetooth technology for a user-friendly interface and experience.</p><p>Embecta's said its patch pump development program also includes plans to introduce a closed-loop version featuring an insulin-dosing algorithm in a future FDA submission.</p><p>Shares of Embecta were up 2.3% in recent Tuesday trading.</p><p>Price: 16.72, Change: +0.38, Percent Change: +2.33</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Embecta Gets FDA Clearance for Disposable Insulin Patch Pump for Diabetes</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEmbecta Gets FDA Clearance for Disposable Insulin Patch Pump for Diabetes\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-09-03 23:37 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.mtnewswires.com/><strong>MT Newswires Live</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Embecta (EMBC) said Tuesday it has received the US Food and Drug Administration's 510(k) clearance for disposable patch pump for insulin delivery for the treatment of both type 1 and type 2 diabetes....</p>\n\n<a href=\"https://www.mtnewswires.com/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4198","symbol_name":"医疗保健用品","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2464386046","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2464386046","pubTimestamp":1725377851,"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Embecta  said Tuesday it has received the US Food and Drug Administration's 510 clearance for disposable patch pump for insulin delivery for the treatment of both type 1 and type 2 diabetes.The system features a tubeless patch pump with a 300-unit insulin reservoir and a secured controller equipped with Bluetooth technology for a user-friendly interface and experience.Embecta's said its patch pump development program also includes plans to introduce a closed-loop version featuring an insulin-dosing algorithm in a future FDA submission.Shares of Embecta were up 2.3% in recent Tuesday trading.Price: 16.72, Change: +0.38, Percent Change: +2.33","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4198":"医疗保健用品","EMBC":"Embecta Corp."},"translate_title":"Embecta治疗糖尿病的一次性胰岛素贴片泵获得FDA批准","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"EMBC":0.9},"content_text":"Embecta (EMBC) said Tuesday it has received the US Food and Drug Administration's 510(k) clearance for disposable patch pump for insulin delivery for the treatment of both type 1 and type 2 diabetes.The system features a tubeless patch pump with a 300-unit insulin reservoir and a secured controller equipped with Bluetooth technology for a user-friendly interface and experience.Embecta's said its patch pump development program also includes plans to introduce a closed-loop version featuring an insulin-dosing algorithm in a future FDA submission.Shares of Embecta were up 2.3% in recent Tuesday trading.Price: 16.72, Change: +0.38, Percent Change: +2.33","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.28.3","shortVersion":"4.28.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2464386046"}